Vilon Reference

Plain English

What it is

Vilon is a man-made peptide, a very short chain made of just two amino acids (lysine and glutamic acid, written Lys-Glu). It comes from the Russian "peptide bioregulator" research tradition. It is not an FDA-approved medicine.

What people use it for

In bioregulator communities people bring it up for longevity (living longer), supporting the immune system, and some fringe anti-cancer speculation. These are community ideas, not approved or proven medical uses.

What the science shows

The published evidence is old and comes mostly from animal research. One mouse study reported that vilon slowed naturally occurring tumors and lengthened the animals' lives. There is no established human outcome data, so any benefit in people remains unproven.

The catch

Vilon is a research chemical, not an approved drug, and the human evidence simply is not there. The longevity and anti-cancer talk rests on older animal work and community framing, which should not be read as proof that it helps or is safe in people.

Reference summary

Public evidence is preclinical and older, including mouse spontaneous-tumor / lifespan work and compound registry records. Human outcome data are not established.

Regulatory and posture

Categories

Longevity, Immune

Aliases

Lys-Glu, KE dipeptide, Lysylglutamic acid

Evidence posture

preclinical - Preclinical dipeptide. Longevity and anticancer community claims are unproven and should not be read as treatment evidence.

Regulatory status

No FDA-approved Vilon drug label. Vilon is a synthetic dipeptide from the Russian peptide-bioregulator literature and is not an FDA-reviewed longevity, immune, or oncology product.

Content review status

research reference